PERIOSTAT Drug Patent Profile
✉ Email this page to a colleague
When do Periostat patents expire, and what generic alternatives are available?
Periostat is a drug marketed by Collagenex and Galderma Labs Lp and is included in two NDAs.
The generic ingredient in PERIOSTAT is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Periostat
A generic version of PERIOSTAT was approved as doxycycline hyclate by CARIBE HOLDINGS on November 8th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PERIOSTAT?
- What are the global sales for PERIOSTAT?
- What is Average Wholesale Price for PERIOSTAT?
Summary for PERIOSTAT
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 7 |
| Patent Applications: | 438 |
| DailyMed Link: | PERIOSTAT at DailyMed |
Recent Clinical Trials for PERIOSTAT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| M.D. Anderson Cancer Center | Phase 1 |
| Merck Sharp & Dohme Corp. | Phase 1 |
| BioMed Valley Discoveries, Inc | Phase 1 |
US Patents and Regulatory Information for PERIOSTAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collagenex | PERIOSTAT | doxycycline hyclate | CAPSULE;ORAL | 050744-001 | Sep 30, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Galderma Labs Lp | PERIOSTAT | doxycycline hyclate | TABLET;ORAL | 050783-001 | Feb 2, 2001 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
